Bota Biosciences, founded in 2019, has positioned itself as a trailblazer in the intersection of biotechnology and manufacturing. Operating from its headquarters in the United States, Bota is renowned for its innovative approach to biomanufacturing through a unique Physical AI-driven paradigm. By harnessing AI, synthetic biology, and industrialization, Bota's capabilities span from strain engineering to process development, catering to industries such as food, nutrition, and personal care.
The company's slogan, "Deliver on nature's possibilities," reflects its commitment to providing scalable, green solutions and facilitating a shift towards sustainability. With a robust biofoundry platform, Bota collaborates globally to enhance productivity and efficiency in biotechnology.
In its latest funding round, Bota secured a substantial $100.00M Series B investment on 29 July 2021 from prominent investors, including Source Code Capital, Matrix Partners China, 5Y Capital, Sherpa Healthcare Partners, and Sequoia Capital China, propelling its growth trajectory and innovation efforts.